
|Articles|September 1, 2001
Engineered Tissue Successfully Heals Diabetic Ulcers Over 12 Weeks
NEW YORK - OrCel, an engineered tissue produced by Ortec International, showed greater than 100 percent improvement over standard of care in diabetic ulcers the size of 6 cm2 or less,according to interim 12-week clinical data from a trial pilot conducted by the company.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5



















